MoneyWorks4Me

Innova Captab - Quaterly Results

29 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 1981.02 millions as compared to Rs. 2165.63 millions during the year-ago period.A good growth in profit of 46.06% reported to Rs. 197.20  millions over Rs. 135.01 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 293.97 millions from 241.45 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1981.02 2165.63 -8.52 8649.29 8586.73 0.73 8649.29 8586.73 0.73
Other Income 60.08 24.68 143.44 107.18 87.34 22.72 107.18 87.34 22.72
PBIDT 293.97 241.45 21.75 1186.88 1072.63 10.65 1186.88 1072.63 10.65
Interest 1.20 49.75 -97.59 135.91 183.00 -25.73 135.91 183.00 -25.73
PBDT 292.77 191.70 52.72 1050.97 889.63 18.14 1050.97 889.63 18.14
Depreciation 29.29 28.38 3.21 113.99 106.56 6.97 113.99 106.56 6.97
PBT 263.48 163.32 61.33 936.98 783.07 19.65 936.98 783.07 19.65
TAX 66.28 28.31 134.12 255.37 207.55 23.04 255.37 207.55 23.04
Deferred Tax -2.57 3.47 -174.06 3.53 18.94 -81.36 3.53 18.94 -81.36
PAT 197.20 135.01 46.06 681.61 575.52 18.43 681.61 575.52 18.43
Equity 572.25 480.00 19.22 572.25 480.00 19.22 572.25 480.00 19.22
PBIDTM(%) 14.84 11.15 33.10 13.72 12.49 9.85 13.72 12.49 9.85
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..